With the recent proliferation of advanced diabetes technology, people with Type 1 diabetes now enjoy an unprecedented ability to assess and fine…
Category: Artificial Pancreas
The U.S. FDA has authorized marketing of the Tandem Diabetes Care Control-IQ Technology, an interoperable automated glycemic controller device…
Are two hormones better than one? A new clinical trial aims to find out.
Massachusetts startup Beta Bionics and Danish biotech firm Zealand Pharma…
The diabetes device company, Tandem Diabetes Care, manufacturer of the only touchscreen insulin pumps available in the United States, today…
In October, JDRF took the organization’s first step into the burgeoning world of DIY diabetes technology when it announced a new initiative to…
Bigfoot Biomedical has a lot going for it. It’s got intrigue (read the story about its co-founder Bryan Mazlish in Wired); it has respected industry…
For people with diabetes, implanted medical devices can enable better treatment. A new study has shown that selectively blocking immune cells…
Not to be confused with that other big name company leaning on the Latin prefix Med––um, Medtronic––is another diabetes management company called…
But here’s the thing: this is not one product. This is not one moment in time. This is an entire new generation of tools and treatment, and it needs an umbrella name for it all to be grouped under. JDRF called it the APP – Artificial Pancreas Project – because it is just that. A project. A mission. Not just one finite goal.
The 670G actually uses data from the sensor to give you insulin. This is an enormous step toward a genuine closed loop/artificial pancreas system, and is a really big deal.